US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 28.260
  • +3.690+15.02%
Close May 28 16:00 ET
  • 28.540
  • +0.280+0.99%
Post 18:38 ET
502.92MMarket Cap-504P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

5.84M

-1.65%
EPS(YoY)

-10.50

-147.64%
Analyst Rating

Strong Buy

May 28, 2024

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q15.840M / 0.000--
--2023/Q4-- / 2.500M--
--2023/Q36.551M / 11.025M--
--2023/Q25.249M / 11.092M--
--2023/Q15.938M / 12.139M--
--2022/Q416.795M / 11.685M--
--2022/Q320.710M / 25.214M--
--2022/Q239.273M / 16.078M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q15.840M / 0.000--
--2023/Q4-- / 2.500M--
--2023/Q36.551M / 11.025M--
--2023/Q25.249M / 11.092M--
--2023/Q15.938M / 12.139M--
--2022/Q416.795M / 11.685M--
--2022/Q320.710M / 25.214M--
--2022/Q239.273M / 16.078M--

Unlock Free Earnings Estimates

Cartesian Therapeutics Earnings Reports

  • Cartesian Therapeutics | 10-Q: Quarterly report

    May 8 06:08

  • Cartesian Therapeutics | 10-K: Annual report

    Mar 7 06:14

  • Cartesian Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 15:31

  • SELECTA BIOSCIENCES | 10-Q: Q2 2023 Earnings Report

    Aug 17, 2023 06:13

    • Read more

    Analysis

    Analyst Rating

    Updated: May 28, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg